Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

NCT05881837 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: HRS9531 injection
DRUG: HRS9531 injection
DRUG: HRS9531 injection
DRUG: HRS9531 injection
DRUG: HRS9531 injection Placebo
DRUG: HRS9531 injection Placebo
DRUG: HRS9531 injection Placebo
DRUG: HRS9531 injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.